Company news
Veritas In Silico Inc. news in 2026
Veritas In Silico Inc.'s news releases, calls and decks from 2026, newest first.
Announcement of Patent Grant for a Novel Nucleic Acid Therapeutic for Amyotrophic Lateral Sclerosis (ALS)
November 16, 2026
Revised Financial Forecast for the Fiscal Year Ending December 31, 2026
November 11, 2026
Non-consolidated Financial Results for the Nine Months Ended September 30, 2026 [Under Japanese GAAP]
November 11, 2026
FY2026 Third Quarter Financial Briefing Materials
November 11, 2026
Completion of Pre-development Consultation with PMDA and Future Prospects for Proprietary Drug Delivery System "Perfusio(R)"
November 11, 2026
Monthly Status of Exercise of #5 (with Exercise Price Adjustment Clause) and #6 to #9 Share Acquisition Rights(with Target Issue and Adjustment Optio
November 2, 2026
Syntara and Veritas In Silico sign MoU to Accelerate Joint Discovery Research for mRNA-Targeted Compounds
November 2, 2026
Notice of Completion of Payment for #5 and #6 to #9 Share Acquisition Rights by Third-Party Allotment
October 28, 2026
Notice Concerning Achievement of Research Milestone under Joint Drug Discovery with Toray Industries, Inc.
October 19, 2026
Non-consolidated Financial Results for the Six Months Ended June 30, 2026 [Under Japanese GAAP]
August 5, 2026
Joint Patent Application Filed for lncRNA-Targeting Drugs
August 2, 2026
Personnel Changes in Executive Officer
July 13, 2026
TABLE-Veritas In Silico -2025 parent results
February 11, 2026
Decks in 2026
- Q3 2026 Earnings Presentation
Earnings · 21 slides · Nov 11, 2026
- Investor Presentation (October 2026)
Investor deck · 24 slides · Oct 13, 2026
- Q2 2026 Earnings Presentation
Earnings · 34 slides · Aug 5, 2026
- Q1 2026 Earnings Presentation
Earnings · 19 slides · May 11, 2026
- Investor Presentation (February 2026)
Investor deck · 62 slides · Feb 12, 2026
- FY2025 Earnings Presentation
Earnings · 31 slides · Feb 12, 2026